{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:56:33Z","timestamp":1778964993993,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Branch-like enhancement (BLE) on contrast-enhanced (CE) magnetic resonance imaging (MRI) was found to be effective in differentiating primary central nervous system lymphoma (PCNSL) from high-grade glioma (HGG) in the cerebellum. However, whether it can be applied to assessments of secondary central nervous system lymphoma (SCNSL), or other cerebellar lesions is unknown. Hence, we retrospectively reviewed cerebellar masses to investigate the use of BLE in differentiating cerebellar lymphoma (CL), both primary and secondary, from other lesions. Two reviewers qualitatively evaluated the presence and degree of BLE on CE-T1 weighted imaging (T1WI). If multiple views were available, we determined the view in which BLE was the most visible. Seventy-five patients with the following pathologies were identified:17 patients with CL, 30 patients with metastasis, 12 patients with hemangioblastoma, 9 patients with HGG, and 7 patients with others. Twelve patients presented with PCNSL and five with SCNSL. Of 17 patients with CL, 15 (88%) had BLE, whereas three (5%) out of 58 patients in the non-CL group showed BLE. In patients who underwent three-dimensional-CE-T1WI, BLE was the most visible on the sagittal image. In conclusion, BLE is a highly specific finding for CL and the sagittal image is important in evaluating this finding.<\/jats:p>","DOI":"10.1038\/s41598-022-07581-x","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T13:37:47Z","timestamp":1646401067000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Branch-like enhancement on contrast enhanced MRI is a specific finding of cerebellar lymphoma compared with other pathologies"],"prefix":"10.1038","volume":"12","author":[{"given":"Kota","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Karakama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoki","family":"Inaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketoshi","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ukihide","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"7581_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2012. CA Cancer J. Clin. 62, 10\u201329. https:\/\/doi.org\/10.3322\/caac.20138 (2012).","journal-title":"CA Cancer J. Clin."},{"key":"7581_CR2","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.hoc.2005.05.008","volume":"19","author":"S Montoto","year":"2005","unstructured":"Montoto, S. & Lister, T. A. Secondary central nervous system lymphoma: risk factors and prophylaxis. Hematol. Oncol. Clin. N. Am. 19, 751-763,viii. https:\/\/doi.org\/10.1016\/j.hoc.2005.05.008 (2005).","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"7581_CR3","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/ajh.23551","volume":"88","author":"BP O'Neill","year":"2013","unstructured":"O\u2019Neill, B. P., Decker, P. A., Tieu, C. & Cerhan, J. R. The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin\u2019s lymphoma. Am. J. Hematol. 88, 997\u20131000. https:\/\/doi.org\/10.1002\/ajh.23551 (2013).","journal-title":"Am. J. Hematol."},{"key":"7581_CR4","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/bjc.2011.357","volume":"105","author":"JL Villano","year":"2011","unstructured":"Villano, J. L., Koshy, M., Shaikh, H., Dolecek, T. A. & McCarthy, B. J. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma. Br. J. Cancer 105, 1414\u20131418. https:\/\/doi.org\/10.1038\/bjc.2011.357 (2011).","journal-title":"Br. J. Cancer"},{"key":"7581_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1001\/jamaneurol.2013.606","volume":"70","author":"BJ Scott","year":"2013","unstructured":"Scott, B. J., Douglas, V. C., Tihan, T., Rubenstein, J. L. & Josephson, S. A. A systematic approach to the diagnosis of suspected central nervous system lymphoma. JAMA Neurol. 70, 311\u2013319. https:\/\/doi.org\/10.1001\/jamaneurol.2013.606 (2013).","journal-title":"JAMA Neurol."},{"key":"7581_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1532\/ijh97.06091","volume":"84","author":"N Tomita","year":"2006","unstructured":"Tomita, N., Kodama, F., Kanamori, H., Motomura, S. & Ishigatsubo, Y. Secondary central nervous system lymphoma. Int. J. Hematol. 84, 128\u2013135. https:\/\/doi.org\/10.1532\/ijh97.06091 (2006).","journal-title":"Int. J. Hematol."},{"key":"7581_CR7","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.3109\/10428194.2013.869326","volume":"55","author":"CD Fletcher","year":"2014","unstructured":"Fletcher, C. D. & Kahl, B. S. Central nervous system involvement in diffuse large B-cell lymphoma: an analysis of risks and prevention strategies in the post-rituximab era. Leuk. Lymphoma 55, 2228\u20132240. https:\/\/doi.org\/10.3109\/10428194.2013.869326 (2014).","journal-title":"Leuk. Lymphoma"},{"key":"7581_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3109\/10428194.2013.811239","volume":"55","author":"J Zhang","year":"2014","unstructured":"Zhang, J., Chen, B. & Xu, X. Impact of rituximab on incidence of and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: A systematic review and meta-analysis. Leuk. Lymphoma 55, 509\u2013514. https:\/\/doi.org\/10.3109\/10428194.2013.811239 (2014).","journal-title":"Leuk. Lymphoma"},{"key":"7581_CR9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1148\/radiol.14131895","volume":"272","author":"CH Suh","year":"2014","unstructured":"Suh, C. H. et al. Atypical imaging features of primary central nervous system lymphoma that mimics glioblastoma: Utility of intravoxel incoherent motion MR imaging. Radiology 272, 504\u2013513. https:\/\/doi.org\/10.1148\/radiol.14131895 (2014).","journal-title":"Radiology"},{"key":"7581_CR10","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1200\/jco.2005.13.524","volume":"23","author":"LE Abrey","year":"2005","unstructured":"Abrey, L. E. et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J. Clin. Oncol. 23, 5034\u20135043. https:\/\/doi.org\/10.1200\/jco.2005.13.524 (2005).","journal-title":"J. Clin. Oncol."},{"key":"7581_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3174\/ajnr.A3165","volume":"34","author":"FE Valles","year":"2013","unstructured":"Valles, F. E. et al. Combined diffusion and perfusion MR imaging as biomarkers of prognosis in immunocompetent patients with primary central nervous system lymphoma. AJNR Am. J. Neuroradiol. 34, 35\u201340. https:\/\/doi.org\/10.3174\/ajnr.A3165 (2013).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"7581_CR12","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.crad.2016.05.017","volume":"71","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y., Zhang, Q., Wang, X. X., Deng, X. F. & Zhu, Y. Z. Value of pretherapeutic DWI in evaluating prognosis and therapeutic effect in immunocompetent patients with primary central nervous system lymphoma given high-dose methotrexate-based chemotherapy: ADC-based assessment. Clin. Radiol. 71, 1018\u20131029. https:\/\/doi.org\/10.1016\/j.crad.2016.05.017 (2016).","journal-title":"Clin. Radiol."},{"key":"7581_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1212\/wnl.57.3.393","volume":"57","author":"U B\u00fchring","year":"2001","unstructured":"B\u00fchring, U. et al. MRI features of primary central nervous system lymphomas at presentation. Neurology 57, 393\u2013396. https:\/\/doi.org\/10.1212\/wnl.57.3.393 (2001).","journal-title":"Neurology"},{"key":"7581_CR14","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3174\/ajnr.A1447","volume":"30","author":"IS Haldorsen","year":"2009","unstructured":"Haldorsen, I. S., Kr\u00e5kenes, J., Krossnes, B. K., Mella, O. & Espeland, A. CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989\u20132003. AJNR Am. J. Neuroradiol. 30, 744\u2013751. https:\/\/doi.org\/10.3174\/ajnr.A1447 (2009).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"7581_CR15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10072-018-3669-7","volume":"40","author":"G Cheng","year":"2019","unstructured":"Cheng, G. & Zhang, J. Imaging features (CT, MRI, MRS, and PET\/CT) of primary central nervous system lymphoma in immunocompetent patients. Neurol. Sci 40, 535\u2013542. https:\/\/doi.org\/10.1007\/s10072-018-3669-7 (2019).","journal-title":"Neurol. Sci"},{"key":"7581_CR16","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3174\/ajnr.A2171","volume":"32","author":"IS Haldorsen","year":"2011","unstructured":"Haldorsen, I. S., Espeland, A. & Larsson, E.-M. Central nervous system lymphoma: Characteristic findings on traditional and advanced imaging. Am. J. Neuroradiol. 32, 984\u2013992. https:\/\/doi.org\/10.3174\/ajnr.A2171 (2011).","journal-title":"Am. J. Neuroradiol."},{"key":"7581_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12883-019-1511-3","volume":"19","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. Parenchymal central nervous system involvement in aggressive B-cell lymphoma: Retrospective analysis of clinical and MRI features in a Chinese population. BMC Neurol. 19, 268. https:\/\/doi.org\/10.1186\/s12883-019-1511-3 (2019).","journal-title":"BMC Neurol."},{"key":"7581_CR18","first-page":"318","volume":"37","author":"E Koubska","year":"2016","unstructured":"Koubska, E., Weichet, J. & Malikova, H. Central nervous system lymphoma: A morphological MRI study. Neuro Endocrinol. Lett. 37, 318\u2013324 (2016).","journal-title":"Neuro Endocrinol. Lett."},{"key":"7581_CR19","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2147\/NDT.S157959","volume":"14","author":"H Malikova","year":"2018","unstructured":"Malikova, H. et al. Secondary central nervous system lymphoma: Spectrum of morphological MRI appearances. Neuropsychiatr. Dis. Treat. 14, 733\u2013740. https:\/\/doi.org\/10.2147\/NDT.S157959 (2018).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"7581_CR20","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/bf00602829","volume":"35","author":"RK Gupta","year":"1993","unstructured":"Gupta, R. K. et al. Unusual enhancement on gadolinium-enhanced MRI in a case of primary cerebellar lymphoma. Neuroradiology 35, 454\u2013456. https:\/\/doi.org\/10.1007\/bf00602829 (1993).","journal-title":"Neuroradiology"},{"key":"7581_CR21","doi-asserted-by":"publisher","first-page":"10007","DOI":"10.1038\/s41598-020-67080-9","volume":"10","author":"YX He","year":"2020","unstructured":"He, Y. X., Qu, C. X., He, Y. Y., Shao, J. & Gao, Q. Conventional MR and DW imaging findings of cerebellar primary CNS lymphoma: Comparison with high-grade glioma. Sci. Rep. 10, 10007. https:\/\/doi.org\/10.1038\/s41598-020-67080-9 (2020).","journal-title":"Sci. Rep."},{"key":"7581_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/19714009211014129","volume":"34","author":"J Oyama","year":"2021","unstructured":"Oyama, J. et al. Incidental T2 hyperintensities in the medial part of the bilateral globus pallidus are possibly an age-related physiological finding. Neuroradiol. J. 34, 575\u2013584. https:\/\/doi.org\/10.1177\/19714009211014129 (2021).","journal-title":"Neuroradiol. J."},{"issue":"65","key":"7581_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1590\/1806-9282.65.2.136","volume":"1992","author":"GL Beraldo","year":"2019","unstructured":"Beraldo, G. L. et al. Primary infratentorial diffuse large b-cell lymphoma: A challenging diagnosis in an immunocompetent patient. Rev. Assoc. Med. Bras. 1992(65), 136\u2013140. https:\/\/doi.org\/10.1590\/1806-9282.65.2.136 (2019).","journal-title":"Rev. Assoc. Med. Bras."},{"key":"7581_CR24","doi-asserted-by":"publisher","first-page":"796","DOI":"10.5137\/1019-5149.jtn.10594-14.1","volume":"25","author":"J Yamamoto","year":"2015","unstructured":"Yamamoto, J., Kitagawa, T., Akiba, D. & Nishizawa, S. 5-Aminolevulinic acid-induced fluorescence in cerebellar primary central nervous system lymphoma: A case report and literature review. Turk. Neurosurg. 25, 796\u2013800. https:\/\/doi.org\/10.5137\/1019-5149.jtn.10594-14.1 (2015).","journal-title":"Turk. Neurosurg."},{"key":"7581_CR25","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.3109\/10428194.2011.580480","volume":"52","author":"Y Fl\u00f8isand","year":"2011","unstructured":"Fl\u00f8isand, Y. et al. Richter syndrome presenting as a solitary cerebellar tumor during first-line treatment for chronic lymphocytic leukemia. Leuk. Lymphoma 52, 2007\u20132009. https:\/\/doi.org\/10.3109\/10428194.2011.580480 (2011).","journal-title":"Leuk. Lymphoma"},{"key":"7581_CR26","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1093\/brain\/awq164","volume":"133","author":"SJ Pittock","year":"2010","unstructured":"Pittock, S. J. et al. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain J. Neurol. 133, 2626\u20132634. https:\/\/doi.org\/10.1093\/brain\/awq164 (2010).","journal-title":"Brain J. Neurol."},{"key":"7581_CR27","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/s0140-6736(11)60165-7","volume":"378","author":"JP van Meerbeeck","year":"2011","unstructured":"van Meerbeeck, J. P., Fennell, D. A. & De Ruysscher, D. K. Small-cell lung cancer. Lancet 378, 1741\u20131755. https:\/\/doi.org\/10.1016\/s0140-6736(11)60165-7 (2011).","journal-title":"Lancet"},{"key":"7581_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.crad.2018.10.012","volume":"74","author":"X Xu","year":"2019","unstructured":"Xu, X. et al. Clinical utility of quantitative dual-energy CT iodine maps and CT morphological features in distinguishing small-cell from non-small-cell lung cancer. Clin. Radiol. 74, 268\u2013277. https:\/\/doi.org\/10.1016\/j.crad.2018.10.012 (2019).","journal-title":"Clin. Radiol."},{"key":"7581_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3174\/ajnr.A5516","volume":"39","author":"WS Jung","year":"2018","unstructured":"Jung, W. S., Park, C. H., Hong, C. K., Suh, S. H. & Ahn, S. J. Diffusion-weighted imaging of brain metastasis from lung cancer: Correlation of MRI parameters with the histologic type and gene mutation status. AJNR Am. J. Neuroradiol. 39, 273\u2013279. https:\/\/doi.org\/10.3174\/ajnr.A5516 (2018).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"7581_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-018-2938-x","volume":"140","author":"A Morales La Madrid","year":"2018","unstructured":"Morales La Madrid, A., Ranjan, S. & Warren, K. E. Gliomatosis cerebri: a consensus summary report from the Second International Gliomatosis cerebri Group Meeting, June 22-23, 2017, Bethesda, USA. J. Neuro-oncol. 140, 1\u20134. https:\/\/doi.org\/10.1007\/s11060-018-2938-x (2018).","journal-title":"J. Neuro-oncol."},{"key":"7581_CR31","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s00330-020-07296-5","volume":"31","author":"F Fu","year":"2021","unstructured":"Fu, F. et al. Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict chemotherapeutic responses and survival in primary central-nervous-system lymphoma. Eur. Radiol. 31, 1863\u20131871. https:\/\/doi.org\/10.1007\/s00330-020-07296-5 (2021).","journal-title":"Eur. Radiol."},{"key":"7581_CR32","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1148\/radiol.14132740","volume":"272","author":"P Kickingereder","year":"2014","unstructured":"Kickingereder, P. et al. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging. Radiology 272, 843\u2013850. https:\/\/doi.org\/10.1148\/radiol.14132740 (2014).","journal-title":"Radiology"},{"key":"7581_CR33","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/jmri.26602","volume":"50","author":"CH Suh","year":"2019","unstructured":"Suh, C. H. et al. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis. J. Magn. Resonance Imaging 50, 560\u2013572. https:\/\/doi.org\/10.1002\/jmri.26602 (2019).","journal-title":"J. Magn. Resonance Imaging"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07581-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07581-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07581-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T23:29:37Z","timestamp":1669332577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07581-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7581"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-07581-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"2 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3591"}}